Product Images Hydrocodone Polistirex And Chlorpheniramine Polistirex Extended-release

This text provides a conversion table for measuring ingredients in teaspoons and milliliters. 1 tsp is equivalent to 5 mL, while 0.5 tsp is equivalent to 2.5 mL.*

This is a description of a medication with the NDC number 27808-086-01. The medication is an extended-release suspension containing Hydrocodone Polistirex and Chlorpheniramine Polistirex equivalent to 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate per 5 mL. It is intended for dosing every 12 hours and is contraindicated for children under 6 years of age. The medication guide must be offered to each patient by the pharmacist. This medication must be shaken well before using and contains sodium metabisulphite, which may cause allergic-type reactions. It is recommended to store the medication at a controlled room temperature of 20-25°C (68-77°F), with excursions of 15-30°C (59-86°F).*

This is a product description of a medication named Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension. It is a 12-hour dosing medication which is used in adults and children (above 6 years of age). It contains 10 mg hydrocodone bitartrate equivalent and 8 mg chlorpheniramine maleate per 5 mL. The package contains 115 mL (one dosing cup) of the suspension, medication guide and package insert which contraindicated the medication for children below six years of age. Additional information is provided on dosage, warnings and storage temperatures.*

This text provides information on a medication called Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension. Each 5 mL of the suspension contains the equivalent of 10 mg hydrocodone bitartrate and 8 mg chlorpheniramine maleate. The medication is used every 12 hours and is contraindicated for children under 6 years old. The medication comes in a 16 oz (473 mL) bottle and should be dispensed in a tight, light-resistant container. The manufacturer is Tris Pharma, and precautions should be taken to keep all medications out of reach of children. The medication contains sodium metabisulfite, which may cause allergic reactions. The warning indicates to protect the medication from light and store at 20-25°C (68 to 77°F).*

This is a description of a medication with NDC 27806.086.03, which is an extended-release suspension of Hydrocodone Polistirex and Chlorpheniramine Polistirex. Each 5 mL of the suspension contains 10 mg of hydrocodone bitartrate and 8 mg of chlorpheniramine maleate. It is indicated for use in adults and children 12 years and older for the relief of allergy symptoms. The dosing interval is every 12 hours for adults, and for children aged 6-11 years, it should be 25 mg every 12 hours. It is contraindicated for use in children under six years. The medication should be stored at controlled room temperature.*

This is a description of a medication called Void Aqueous consisting of Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension. It is equivalent to 10 mg of hydrocodone bitarfrate and 8 mg of chlorpheniramine maleate per 5 mL and is intended for 12-hour dosing. The medication is contraindicated in children under 6 years of age. The package should be shaken well and dispensed as one unit. The total volume of the medication is 70 mL.*